biological source
rat
Quality Level
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
1-1-F11 s.E6, monoclonal
form
buffered aqueous solution
mol wt
antigen ~50 kDa
species reactivity
rat, monkey, human
concentration
~1 mg/mL
technique(s)
immunocytochemistry: 5-10 μg/mL using D1 dopamine receptor transfected HEK-293T cells, immunohistochemistry: suitable, western blot: suitable
isotype
IgG2a
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... DRD1(1812)
rat ... Drd1a(24316)
General description
D1 多巴胺受体编码多巴胺受体的 D1 亚型。D1 亚型是中枢神经系统中含量最丰富的多巴胺受体。这种 G 蛋白偶联受体刺激腺苷酸环化酶并激活环腺苷酸依赖性蛋白激酶。
单克隆抗D1多巴胺受体(大鼠IgG2a同种型)来源于通过融合小鼠骨髓瘤细胞而杂交瘤1-1-F11 S.E6和使用含人D1多巴胺受体C-端97氨基酸重组融合蛋白免疫大鼠脾细胞。多巴胺受体属于7个跨膜结构域G蛋白偶联受体家族。多巴胺受体主要分布在纹状体、边缘系统、大脑皮层和下丘脑漏斗。D1类家族包括D1受体和D5受体。
Immunogen
含有人多巴胺 D 1 受体 C 末端 97 氨基酸的重组融合蛋白。
Application
大鼠单克隆抗D1多巴胺受体抗体可用于:
- 免疫组化
- 免疫印迹
- 免疫细胞化学
- 邻位连接检测
- 免疫共沉淀
- 蛋白质印迹
Biochem/physiol Actions
D1 受体调节神经元生长和发育,介导一些行为反应,并调节多巴胺受体D2介导的事件。D1 受体在气道平滑肌(ASM)上表达,通过 cAMP 激活蛋白激酶 A 调节平滑肌张力。它是治疗性 ASM 松弛的潜在靶点。
Physical form
0.01M 磷酸缓冲盐溶液,pH 7.4,含 15mM 叠氮化钠。
Legal Information
根据埃默里大学的独家许可证销售
Disclaimer
除非我们的产品目录或产品随附的其他公司文件中另有说明,否则我们的产品仅用于研究用途,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、体外或体内治疗用途或任何类型的人类或动物消费或应用。
Still not finding the right product?
试用我们的 产品选型工具 工具缩小选择范围
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
法规信息
低风险生物材料
常规特殊物品
此项目有
D1R/GluN1 complexes in the striatum integrate dopamine and glutamate signalling to control synaptic plasticity and cocaine-induced responses
Cahill E, et al.
Molecular Psychiatry, 19(12), 1295-1295 (2014)
Matthieu F Bastide et al.
Scientific reports, 7(1), 2348-2348 (2017-05-26)
A whole brain immediate early gene mapping highlighted the dorsolateral bed nucleus of the stria terminalis (dlBST) as a structure putatively involved in L-3,4-dihydroxyphenylalanine (L-Dopa)-induced dyskinesia (LID), the debilitating side-effects of chronic dopamine replacement therapy in Parkinson's disease (PD). dlBST
E Cahill et al.
Molecular psychiatry, 19(12), 1295-1304 (2014-07-30)
Convergent dopamine and glutamate signalling onto the extracellular signal-regulated kinase (ERK) pathway in medium spiny neurons (MSNs) of the striatum controls psychostimulant-initiated adaptive processes underlying long-lasting behavioural changes. We hypothesised that the physical proximity of dopamine D1 (D1R) and glutamate
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| D2944-100UL | 04061833562741 |